For the quarter ending 2025-11-01, DDS had $137,190K increase in cash & cash equivalents over the period. $156,151K in free cash flow.
| Cash Flow | 2025-11-01 | 2025-08-02 |
|---|---|---|
| Net income | 129,810 | 236,652 |
| Depreciation and amortization of property and other deferred costs | 44,761 | 89,889 |
| Gain on disposal of assets | 577 | 4,900 |
| Accrued interest on short-term investments | 1,361 | 5,610 |
| Decrease (increase) in accounts receivable | -7,311 | -3,488 |
| Increase in merchandise inventories | 498,306 | 47,718 |
| Decrease in other current assets | -15,084 | -7,434 |
| Decrease (increase) in other assets | -878 | -1,114 |
| Increase in trade accounts payable and accrued expenses and other liabilities | 450,661 | -24,522 |
| Increase (decrease) in income taxes payable | 38,201 | 63,566 |
| Net cash provided by operating activities | 186,462 | 319,393 |
| Purchase of property and equipment and capitalized software | 30,311 | 43,527 |
| Proceeds from disposal of assets | 1,578 | 6,029 |
| Proceeds from insurance | 0 | 1,521 |
| Purchase of short-term investments | 122,840 | 273,497 |
| Proceeds from maturities of short-term investments | 138,770 | 404,970 |
| Investments related to joint ventures | 32,555 | 1,750 |
| Net cash provided by (used in) investing activities | -45,358 | 93,746 |
| Cash dividends paid | 3,904 | 7,900 |
| Purchase of treasury stock | 0 | 107,756 |
| Issuance cost of line of credit | 10 | 3,326 |
| Net cash used in financing activities | -3,914 | -118,982 |
| Increase in cash and cash equivalents | 137,190 | 294,157 |
| Cash and cash equivalents at beginning of period | 717,854 | - |
| Cash and cash equivalents at end of period | 1,149,201 | - |
DILLARD'S, INC. (DDS)
DILLARD'S, INC. (DDS)